Social and behavioral predictors of two-doses 4CMenB vaccine series among adolescents enrolled in a cluster randomized controlled trial in Australia

References

• Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–9.
   PubMedGoogle Scholar
• Chang Q, Tzeng Y-L, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012;4:237–45.
   PubMedGoogle Scholar
• Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolescent Health. 2016;59(2, Supplement):S3–S11. doi:10.1016/j.jadohealth.2016.04.012.
   PubMed Web of Science ®Google Scholar
• Borrow R, Alarcón P, Carlos J, Caugant DA, Christensen H, Debbag R, De Wals P, Echániz-Aviles G, Findlow J, Head C, et al. The global meningococcal initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16(4):313–28. doi:10.1080/14760584.2017.1258308.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Tzanakaki G, Kriz P. Lessons from meningococcal carriage studies. FEMS Microbiol Rev. 2007;31(1):52–63. doi:10.1111/j.1574-6976.2006.00052.x.
   PubMed Web of Science ®Google Scholar
• MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MCJ, et al. Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis. 2006;12(6):950–57. doi:10.3201/eid1206.051297.
   PubMed Web of Science ®Google Scholar
• Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–61. doi:10.1016/S1473-3099(10)70251-6.
   PubMed Web of Science ®Google Scholar
• Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 Years - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1109–16. doi:10.15585/mmwr.mm6933a1.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909–17.
   Google Scholar
• Niccolai LM, Hansen CE. Suboptimal uptake of meningococcal vaccines among older adolescents: barriers, solutions, and future research directions. Hum Vaccin Immunother. 2020;16(12):3208–12. doi:10.1080/21645515.2020.1754052.
   PubMed Web of Science ®Google Scholar
• Kuhdari P, Stefanati A, Lupi S, Valente N, Meningococcal GG. B vaccination: real-world experience and future perspectives. Pathog Glob Health. 2016;110:148–56.
   PubMed Web of Science ®Google Scholar
• Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, Stephens DS, MacNeil JR. Meningococcal Vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1–41. doi:10.15585/mmwr.rr6909a1.
   PubMed Web of Science ®Google Scholar
• Marshall HS, Wang B, Andraweera P, McMillan M, Giles L, Almond S, A'Houre M, Lally N, Denehy E, Koehler A, et al. 4CMenB vaccine impact and effectiveness against meningococcal disease and gonorrhoea in a world first infant, child and adolescent program in South Australia. The 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID): online meeting; 2021 May 4 to 29; Geneva, Switzerland. Available from: https://keneswp.azureedge.net/wp-content/uploads/sites/133/2021/05/ESPID-2021-Abstract-Book.pdf .
   Google Scholar
• National Centre for Immunisation Research and Surveillance. Meningococcal vaccines for Australians 2020 [cited 2021 June 04]. Available from: https://www.ncirs.org.au/sites/default/files/2020-06/Meningococcal%20vaccines%20for%20Australians%20fact%20sheet_1%20July%202020_Final_0.pdf.
   Google Scholar
• Ali A, Jafri RZ, Messonnier N, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, et al. Global practices of meningococcal vaccine use and impact on invasive disease. Pathog Glob Health. 2014;108(1):11–20. doi:10.1179/2047773214Y.0000000126.
   PubMed Web of Science ®Google Scholar
• Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15(2):459–69. doi:10.1080/21645515.2018.1528831.
   PubMed Web of Science ®Google Scholar
• kDas JK, Salam RA, Arshad A, Lassi ZS, Bhutta ZA. Systematic review and meta-analysis of interventions to improve access and coverage of adolescent immunizations. J Adolescent Health. 2016;59(4, Supplement):S40–S8. doi:10.1016/j.jadohealth.2016.07.005.
   PubMed Web of Science ®Google Scholar
• Abdullahi LH, Kagina BM, Ndze VN, Hussey GD, Wiysonge CS. Improving vaccination uptake among adolescents. Cochrane Database Syst Rev. 2020;1:Cd011895.
   PubMedGoogle Scholar
• Sakou II, Tsitsika AK, Papaevangelou V, Tzavela EC, Greydanus DE, Tsolia MN. Vaccination coverage among adolescents and risk factors associated with incomplete immunization. Eur J Pediatr. 2011;170(11):1419–26. doi:10.1007/s00431-011-1456-z.
   PubMed Web of Science ®Google Scholar
• Gallagher KE, Kadokura E, Eckert LO, Miyake S, Mounier-Jack S, Aldea M, Ross DA, Watson-Jones D. Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review. BMC Public Health. 2016;16:172. doi:10.1186/s12889-016-2845-z.
   PubMed Web of Science ®Google Scholar
• Marshall HS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, et al. Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. N Engl J Med. 2020;382(4):318–27. doi:10.1056/NEJMoa1900236.
   PubMed Web of Science ®Google Scholar
• Marshall HS, McMillan M, Koehler A, Lawrence A, MacLennan JM, Maiden MCJ, Ramsay M, Ladhani SN, Trotter C, Borrow R, et al. B part of it protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents. BMJ Open. 2018;8(7):e020988. doi:10.1136/bmjopen-2017-020988.
   PubMed Web of Science ®Google Scholar
• Packnett E, Irwin DE, Novy P, Watson PS, Whelan J, Moore-Schiltz L, Lucci M, Hogea C. Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: a retrospective analysis by vaccine and payer type. Vaccine. 2019;37(39):5899–908. doi:10.1016/j.vaccine.2019.06.065.
   PubMed Web of Science ®Google Scholar
• Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(33):909–17. doi:10.15585/mmwr.mm6733a1.
   PubMed Web of Science ®Google Scholar
• Invasive meningococcal disease national surveillance reports −1 January to 31 December 2017 Canberra Australia: australian government, department of health; 2017 [cited 2021 Feb 18]. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-meningococcal-W.htm.
   Google Scholar
• Read RC, Baxter D, Chadwick DR, Faust SN, Finn A, Gordon SB, Heath PT, Lewis DJM, Pollard AJ, Turner DPJ, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. The Lancet. 2014;384(9960):2123–31. doi:10.1016/S0140-6736(14)60842-4.
   PubMed Web of Science ®Google Scholar
• Kurosky SK, Esterberg E, Irwin DE, Trantham L, Packnett E, Novy P, Whelan J, Hogea C. Meningococcal vaccination among adolescents in the United States: a tale of two age platforms. J Adolesc Health. 2019;65(1):107–15. doi:10.1016/j.jadohealth.2019.02.014.
   PubMed Web of Science ®Google Scholar
• Gowda C, Schaffer SE, Dombkowski KJ, Dempsey AF. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers. BMC Public Health. 2012;12:509. doi:10.1186/1471-2458-12-509.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(41):1171–76. doi:10.15585/mmwr.mm6441a3.
   PubMed Web of Science ®Google Scholar
• Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination. Med J Aust. 2017;207(9):382–87. doi:10.5694/mja16.01340.
   PubMed Web of Science ®Google Scholar
• Spyromitrou-Xioufi P, Tsirigotaki M, Ladomenou F. Risk factors for meningococcal disease in children and adolescents: a systematic review and META-analysis. Eur J Pediatr. 2020;179(7):1017–27. doi:10.1007/s00431-020-03658-9.
   PubMed Web of Science ®Google Scholar
• Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR, Bell TA, Fleming DW, WENGER JD, Perkins BA, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J. 1997;16(10):979–83. doi:10.1097/00006454-199710000-00015.
   PubMed Web of Science ®Google Scholar
• Tully J, Viner RM, Coen PG, Stuart JM, Zambon M, Peckham C, Booth C, Klein N, Kaczmarski E, Booy R, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ (Clinical Research Ed) 2006;332(7539):445–50. doi:10.1136/bmj.38725.728472.BE.
   PubMedGoogle Scholar
• Olea A, Matute I, González C, Delgado I, Poffald L, Pedroni E, Alfaro T, Hirmas M, Nájera M, Gormaz A, et al. Case-control study of risk factors for meningococcal disease in chile. Emerg Infect Dis. 2017;23(7):1070–78. doi:10.3201/eid2307.160129.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Rosenstein NE, Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA. 2001;286(6):688–93. doi:10.1001/jama.286.6.688.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Kreiner CJ, Shutt KA, Messonnier NE, O’Leary M, Stefonek KR, Lin H, Lynfield R, Barrett NL, Arnold KE, et al. Risk factors for meningococcal disease in students in grades 9–12. Pediatr Infect Dis J. 2008;27:3. doi:10.1097/INF.0b013e31815c1b3a.
   Web of Science ®Google Scholar
• Massey P, Aboriginal DD. Torres Strait Islander peoples at higher risk of invasive meningococcal disease in NSW. N S W Public Health Bull. 2008;19(5–6):100–03. doi:10.1071/NB07047.
   PubMedGoogle Scholar